Live Breaking News & Updates on Nanobiotix Company Profile Get Rating

Stay updated with breaking news from Nanobiotix company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nanobiotix S.A. (NASDAQ:NBTX) Short Interest Down 22.1% in April

Nanobiotix S.A. (NASDAQ:NBTX – Get Rating) saw a significant drop in short interest in April. As of April 15th, there was short interest totalling 6,000 shares, a drop of 22.1% from the March 31st total of 7,700 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 1,700 […] ....

Get Rating , Stock Down , Nanobiotix Daily , Nasdaq Nbtx ,

NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023

Conference Call and Webcast to be Held at 2:00 PM CEST/8:00 AM EDT on April 25, 2023 PARIS and CAMBRIDGE, Mass., April 17, 2023 NANOBIOTIX , a late-stage clinical biotechnology company. | April 17, 2023 ....

United States , New York , France General , United Kingdom , Bart Van Rhijn , Conference Call , Laurent Levy , Nasdaq Global Select Market , New York City , Nanobiotix Stock Exchange , Press Release , Iotechnology Nano Fr0011341205 ,

Nanobiotix (NBTX) to Release Quarterly Earnings on Tuesday

Nanobiotix (NASDAQ:NBTX – Get Rating) will be issuing its quarterly earnings data after the market closes on Tuesday, March 28th. Parties that are interested in registering for the company’s conference call can do so using this link. Nanobiotix Price Performance Shares of NBTX opened at $3.45 on Monday. Nanobiotix has a one year low of […] ....

Get Rating , Nanobiotix Daily , Nasdaq Nbtx ,

Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call

PARIS and CAMBRIDGE, Mass., March 27, 2023 NANOBIOTIX , a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with. | March 27, 2023 ....

United States , France General , New York , United Kingdom , Nasdaq Global Select Market , New York City , Nanobiotix Stock Exchange , Press Release , Atients Nano Fr0011341205 ,

Nanobiotix: Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) Regulatory News: Nanobiotix ....

Ligia Vela Reid , Brandon Owens , Kate Mcneil , Pierre Louis Germain , Nanobiotix Communications , French Commercial Code , General Regulation , French Financial Markets Authority , Des March , Euronext Paris Nasdaq , Shareholder Meeting , Investor Relations , Louis Germain ,